Riggs Asset Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Riggs Asset Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-418	Closed	-$16K	–	293
2016 Q4	$16K	Hold	418	–	–	0.01%	172
2016 Q3	$18K	Hold	418	–	–	0.01%	162
2016 Q2	$17K	Hold	418	–	–	0.01%	167
2016 Q1	$17K	Hold	418	–	–	0.01%	152
2015 Q4	$21K	Sell	418 -32,696	-99%	-$1.67M	0.01%	150
2015 Q3	$1.55M	Sell	33,114 -1,012	-3%	-$61K	0.96%	21
2015 Q2	$2.13M	Buy	34,126 +336	+1%	+$20.9K	1.06%	23
2015 Q1	$2.09M	Buy	33,790 +728	+2%	+$43.2K	1%	26
2014 Q4	$1.78M	Buy	+33,062	New	+$1.81M	0.87%	27

Other funds holding XPH

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Riggs Asset Management's XPH Position: Q1 2017 in Review

Riggs Asset Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2017, closing a stake of 418 shares — an estimated $16K sold.

Riggs Asset Management first reported a position in XPH in Q4 2014 and held it in 9 quarters. The position peaked at $2.13M in Q2 2015. 79 funds tracked by Wall St. Rank hold XPH as of Q1 2017.

Riggs Asset Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2017 after selling out during the quarter.
Riggs Asset Management sold 418 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2017, an estimated $16K.
Riggs Asset Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2014 and held it in 9 quarters.
Riggs Asset Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $2.13M in Q2 2015.
79 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2017.

Based on Riggs Asset Management's 13F filing for Q1 2017, filed 1 May 2017.